T
ech
CN
library_books
Mobile
library_books
Laptop/Pc
library_books
Smart Home
library_books
Audio
library_books
Games
Lastnews
Topics
Trending
News
Best Pick
Reviews
How To Do
Search ...
77.4% ORR! Abbisko to present the updated clinical phase Ib data of Pimicotinib (ABSK021) at the 2023 ASCO Annual Meeting
...
The FDA has approved the CSF-1R inhibitor Pimicotinib (ABSK021) of Abbisko Therapeutics to enter the Pivotal Global Multi-center Phase III Clinical Trial
...
menu
TechCN
person
menu
